QLT Inc. (QLTI) Reports Global Visudyne Sales
Tweet
Share
E-mailGet Alerts QLTI Hot Sheet
Join SI Premium – FREE
QLT Inc. (NASDAQ: QLTI) announced global Visudyne sales of US$30.6 million for the quarter and $141.9 million for the full year ended December 31, 2008. Visudyne sales for the fourth quarter declined by 32.7% over the same quarter in 2007 and the full year represented a decrease of 34.0% from annual sales in 2007. Sales in the U.S. for the quarter were $8.0 million, down 20.0% from the prior-year fourth quarter while sales outside the U.S. were $22.6 million, down 36.3% from the same quarter of the prior year.
QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies.[SM]
QLT Inc. is a global biopharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies.[SM]
You May Also Be Interested In
Create E-mail Alert Related Categories
Retail SalesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
